LncRNA Gm4419 regulates inflammatory cytokines expression <italic style="font-style: italic">via</italic> NF-κB signaling pathway in mesangial cells under high glucose condition

您当前的位置：

首页 >

文章列表页 >

LncRNA Gm4419 regulates inflammatory cytokines expression via NF-κB signaling pathway in mesangial cells under high glucose condition

Basic Medicine | 更新时间：2026-01-09

- LncRNA Gm4419 regulates inflammatory cytokines expression via NF-κB signaling pathway in mesangial cells under high glucose condition
- Journal of Third Military Medical University Vol. 40, Issue 7, Pages: 577-583(2018)
- 作者机构：
  
  1.400016 重庆，重庆医科大学基础医学院：细胞生物学及遗传学教研室
  2.400016 重庆，重庆医科大学基础医学院：生物信息学教研室
  3.400016 重庆，重庆医科大学基础医学院：实验教学中心
- 作者简介：
- 基金信息：
  
  the General Program of National Natural Science Foundation of China(81570747)
- DOI：10.16016/j.1000-5404.201711099
  CLC： R322.61;R329.28;R394.2
- Received：13 November 2017，
  
  Revised：2017-12-30，
  
  Published：15 April 2018
- 稿件说明：
移动端阅览
Wenhao JIANG, Hong YI, Rui PENG, et al. LncRNA Gm4419 regulates inflammatory cytokines expression via NF-κB signaling pathway in mesangial cells under high glucose condition[J]. Journal of Third Military Medical University, 2018, 40(7): 577-583.
DOI：

Wenhao JIANG, Hong YI, Rui PENG, et al. LncRNA Gm4419 regulates inflammatory cytokines expression via NF-κB signaling pathway in mesangial cells under high glucose condition[J]. Journal of Third Military Medical University, 2018, 40(7): 577-583. DOI： 10.16016/j.1000-5404.201711099.

摘要

目的

2

探讨长链非编码RNA Gm4419通过核转录因子-kappa B (nuclear factor-kappa B

NF-κB)信号通路对高糖培养的肾小球系膜细胞炎症因子表达的影响。

方法

2

在高、低糖培养的小鼠肾小球系膜细胞中，采用RT-qPCR检测Gm4419的亚细胞分布及NF-κB亚基p50和p65的表达水平；采用RT-qPCR及免疫荧光检测上、下调Gm4419后炎症相关因子TNF-α和MCP-1的表达；采用生物信息技术分析Gm4419与p50和p65关系；采用Western blot检测上、下调Gm4419后细胞核中p50和p65的表达水平，以及检测特异性p50抑制剂对过表达Gm4419影响MCP-1表达的作用。

结果

2

Gm4419在肾小球系膜细胞高糖组表达水平显著高于低糖组(

P

<

0.05)，且主要分布在

系膜细胞的细胞质中。同时，在低糖组过表达Gm4419后MCP-1、TNF-α表达水平显著增加(

P

<

0.01)；而在高糖组沉默Gm4419后MCP-1、TNF-α表达水平显著减少(

P

<

0.01)。此外，Gm4419与NF-κB亚基p50和p65均存在潜在结合位点，过表达Gm4419后胞核p50和p65蛋白表达水平显著增加，NF-κB活化增强(

P

<

0.01)；而沉默Gm4419后胞核p50和p65蛋白表达水平显著降低，NF-κB活化减弱(

P

<

0.01)，且过表达Gm4419增加MCP-1表达的效应可被特异性p50抑制剂阻断。

结论

2

Gm4419可能在促进高糖下系膜细胞炎症因子表达中扮演重要角色，其机制可能涉及NF-κB信号通路。

Abstract

Objective

2

To investigate the mechanism of long non-coding RNA (lncRNA) Gm4419 regulating the expression of inflammatory cytokines in glomerular mesangial cells under high glucose condition

via

mediating nuclear factor-kappa B (NF-κB) signaling pathway.

Methods

2

The subcellular distribution of Gm4419 and expression of NF-κB subunits p50 and p65 were detected by RT-qPCR in mouse glomerular mesangial cells (MCs) under high or low glucose condition. Moreover

RT-qPCR and immunofluorescence assay were used to measure the expression of MCP-1 and TNF-α when Gm4419 was up-or down-regulated. Additionally

bioinformatics analysis was carried out to predict the relationship between Gm4419 and NF-κB. Western blot assay was used to determine the expression of p50 and p65 in the nucleus of MCs

and the effect of specific p50 inhibitor on the expression of MCP-1 was studied in MCs with Gm4419 over-expression.

Results

2

The expression of Gm4419 was significantly higher in MCs under high glucose condition than those under low condition (

P

<

0.05)

and Gm4419 mainly located in the cytoplasm. The expression levels of MCP-1 and TNF-α were significantly increased in the low glucose group when Gm4419 was over-expressed (

P

<

0.01)

while the levels were decreased in high glucose group when Gm4419 was silenced (

P

<

0.01). Moreover

the binding sites of Gm4419 and p

50 and p65 were predicted

and over-expression of Gm4419 resulted in the increases in p50 and p65 expression levels and enhancement in NF-κB activity (

P

<

0.01). However

silencing Gm4419 induced opposite effects (

P

<

0.01). Additionally

specific p50 inhibitor could block the up-reguation of MCP-1 induced by Gm4419 over-expression.

Conclusion

2

Gm4419 may play an important role in the enhanced expression of inflammatory cytokines in mesangial cells under high glucose condition

and its mechanism may be related to the NF-κB signaling pathway.

关键词

Keywords

references

ATKINS R C, ZIMMET P. Diabetic kidney disease: act now or pay later[J]. Kidney Blood Press Res, 2010, 33(1): 48-51. DOI: 10.1159/000285849.

KOLSET S O, REINHOLT F P, JENSSSEN T. Diabetic nephropathy and extracellular matrix[J]. J Histochem Cytochem, 2012, 60(12):976-986. DOI: 10.1369/ 0022155412465073.

MASON R M, WAHAB N A. Extracellular matrix metabolism in diabetic nephropathy[J]. J Am Soc Nephrol, 2003, 14(5): 1358-1373. DOI:10.1097/01.asn.0000065640.77499.d7.

NAVARRO-GONZÁLEZ J F, MORA-FERNÁNDEZ C, MUROS DE FUENTES M, et al . Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy[J ] . Nat Rev Nephrol, 2011, 7(6):327-340. DOI: 10.1038/nrneph.2011.51.

易红, 彭睿, 孙艳, 等. lncRNA-Gm4419对高糖培养的肾小球系膜细胞增殖和纤维化的影响[J].第三军医大学学报, 2017, 39(3): 216-222. DOI: 10.16016 /j.1000-5404.201608102.

YI H, PENG R, SUN Y, et al . Effect of lncRNA-Gm4419 on proliferation and fibrosis in high glucose-inducedglomerulus mesangial cells[J ] . J Third Mil Med Univ, 2017, 39(3): 216-222. DOI: 10.16016 /j.1000-5404.201608102.

SUN Y M, SU Y, LI J, et al . Recent advances in understanding the biochemical and molecular mechanism of diabetic nephropathy[J ] . Biochem Biophys Res Commun, 2013, 433(4):359-361. DOI: 10.1016/j.bbrc.2013.02.120.

PICHLER R, AFKARIAN M, DIETER B P, et al . Immunity and inflammation in diabetic kidney disease: translating mechanisms to biomarkers and treatment targets[J ] . Am J Physiol Renal Physiol, 2017, 312(4): F716-F731. DOI: 10.1152/ajprenal.00314.2016.

HALLER H, BERTRAM A, NADROWITZ F, et al . Monocyte chemoattractant protein-1 and the kidney[J ] . Curr Opin Nephrol Hypertens, 2016, 25(1):42-49. DOI: 10.1097/MNH.0000000000000186.

DURAN-SALGADO M B, RUBIO-GUERRA A F. Diabetic nephropathy and inflammation[J]. World J Diabetes, 2014, 5(3): 393-398. DOI: 10.4239/wjd.v5.i3.393.

SUN Y, PENG R, PENG H, et al . miR-451 suppresses the NF-kappaB-mediated proinflammatory molecules expression through inhibiting LMP7 in diabetic nephropathy[J ] . Mol Cell Endocrinol, 2016, 433:75-86. DOI: 10.1016/j.mce.2016.06.004.

ZHANG E B, KONG R, YIN D D, et al . Long noncoding RNA ANRIL indicates a poor prognosis of gastric cancer and promotes tumor growth by epigenetically silencing of miR-99a/miR-449a[J ] . Oncotarget, 2014, 5(8): 2276-2292.DOI: 10.18632/oncotarget.1902.

YOU J, ZHANG Y, LIU B, et al . MicroRNA-449a inhibits cell growth in lung cancer and regulates long noncoding RNA nuclear enriched abundant transcript 1[J ] . Indian J Cancer, 2014, 51(Suppl 3): e77-e81. DOI: 10.4103/0019-509X.154055.

EMMRICH S, STRELTSOV A, SCHMIDT F, et al .LincRNAs MONC and MIR100HG act as oncogenes in acute megakaryoblastic leukemia[J ] . Mol Cancer, 2014, 13: 171. DOI: 10.1186/1476-4598-13-171.

HU M, WANG R, LI X, et al . LncRNA MALAT1 is dysregulated in diabetic nephropathy and involved in high glucose-induced podocyte injury via its interplay with β-catenin[J ] . J Cell Mol Med, 2017, 21(11):2732-2747. DOI: 10.1111/jcmm.13189..

LONG J, BADAL S S, YE Z, et al . Long noncoding RNA Tug1 regulates mitochondrial bioenergetics in diabetic nephropathy[J ] . J Clin Invest, 2016, 126(11): 4205-4218. DOI: 10.1172/JCI87927.

LI X, ZHOU J, HUANG K. Inhibition of the lncRNA mirt1 attenuates acute myocardial infarction by suppressing NF-κB activation[J]. Cell Physiol Biochem, 2017, 42(3):1153-1164. DOI: 10.1159/000478870.

SUN D, YU Z, FANG X, et al . LncRNA GAS5 inhibits microglial M2 polarization and exacerbates demyelination[J ] . EMBO Rep, 2017, 18(10):1801-1816. DOI: 10.15252/embr.201643668.

TSAI M C, MANOR O, WAN Y, et al . Long noncoding RNA as modular scaffold of histone modification complexes[J ] . Science, 2010, 329(5992):689-693. DOI: 10.1126/science.1192002.

MARTIANOV I, RAMADASS A, SERRA BARROS A, et al . Repression of the human dihydrofolate reductase gene by a non-coding interfering transcript[J ] .Nature, 2007, 445(7128):666-670. DOI: 10.1038/nature 05519.

BAKER R G, HAYDEN M S, GHOSH S. NF-κB, inflammation, and metabolic disease[J]. Cell Metab, 2011, 13(1): 11-22. DOI: 10.1016/j.cmet.2010.12.008.

WANG S, YANG Z, XIONG F, et al . Betulinic acid ameliorates exp erimental diabetic-induced renal inflammation and fibrosis via inhibiting the activation of NF-κB signaling pathway[J ] . Mol Cell Endocrinol, 2016, 434:135-143. DOI: 10.1016/j.mce.2016.06.019..

0

Views

0

下载量

0

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Related Articles

Effect of lncRNA-Gm4419 on proliferation and fibrosis in high glucose-induced glomerulus mesangial cells

Loss-of-function MAVS mutation causes antiviral immunodeficiency: unveiling a novel mechanism linking viral infection to generalized pustular psoriasis in children

Z-Ligustilide ameliorates retinitis pigmentosa via inhibiting PI3K/AKT-inflammation axis: Validation based on network pharmacology and molecular docking

ATF3 regulates macrophage autophagy and inflammatory responses by suppressing ATG5 and ATG16L1 expression

Effects and underlying mechanisms of novel phenothiazine derivative DA414 in rats with intracerebral hemorrhage

Related Author

易红

彭睿

孙艳

罗勇军

彭惠民

李爱玲

张政

SUN Yanan

Related Institution

Department of Dermatology， Children’s Hospital of Chongqing Medical University

Department of Pediatric Research Institute，Children’s Hospital of Chongqing Medical University， National Clinical Research Center for Child Health and Disorders， Ministry of Education Key Laboratory of Child Development and Disorders

Department of Ophthalmology， First Affiliated Hospital， Army Medical University （Third Military Medical University）

Department of Ophthalmology， General Hospital of Southern Theater Command

Chongqing Key Laboratory of Biochemistry and Molecular Pharmacology

⁰